5G3 — TalkMed Share Price

As of Today at 19:21 UTC, shares in TalkMed are trading at SG$0.43. This share price information is delayed by 15 minutes.

Shares in TalkMed last closed at SG$0.43 and the price had moved by +2.41% over the past 365 days. In terms of relative price strength the TalkMed share price has outperformed the FTSE Developed Asia Pacific Index by +3.12% over the past year.

The overall consensus recommendation for TalkMed is Hold. You can view the full broker recommendation list by unlocking its StockReport.

The TalkMed dividend yield is 5.18% based on the trailing twelve month period.

Last year, TalkMed paid a total dividend of SG$0.02, and it currently has a trailing dividend yield of 5.18%.Looking ahead, shares in TalkMed are due to go ex-dividend on 2024-04-30 and the next dividend pay date is 2024-05-10.

TalkMed are due to go ex-dividend on 2024-04-30 and the next dividend pay date is 2024-05-10. The historic dividend yield on TalkMed shares is currently 5.18%.

To buy shares in TalkMed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of SG$0.43, shares in TalkMed had a market capitalisation of SG$563.83m.

Here are the trading details for TalkMed: 

• Country of listing: Singapore
• Exchange: SES
• Ticker Symbol: 5G3

Based on an overall assessment of its quality, value and momentum TalkMed is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

We could not find analyst target price data for this security.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like TalkMed. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -1.18%.

As of the last closing price of SG$0.43, shares in TalkMed were trading +7.11% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The TalkMed PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.43. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

TalkMed's management team is headed by: 

• S. Chandra Das - NEC
• Peng Tiam Ang - CEO
• Boon Yong Lee - CFO
• Kei Siong Khoo - COO
• Heng Chong Lim - SEC
• Anne Low - SEC
• Leong Ching Ching - NED
• Ching Ching Leong - NED
• Jen Howe Lim - NED
• Teong Jin Lim - NED
• Yock Hian Dan - NID
• Yih Pin Sitoh - NID